Product information

Current status:

Marketed

Current status date:

2022-02-01

Original market date: ^{See footnote 1}

2009-12-10

Product name:

BIBAG

DIN:

02325586 Electronic product monograph is not available

Company:

FRESENIUS MEDICAL CARE CANADA INC
45 Staples Ave, Suite 110
Richmond Hill
Ontario
Canada L4B 4W6

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Haemodialysis

Number of active ingredient(s):

1

Schedule(s):

ETHICAL

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B05ZA HEMODIALYTICS, CONCENTRATES

Active ingredient group (AIG) number:^{See footnote5}

0104153021